ORUKA THERAPEUTICS, INC. — Income Charts
4 quarters of history · ending 2024-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue
$0
R&D
$19M
SG&A
—
D&A
$3K
Operating Income
$-21M
EBITDA
$-21M
Interest Expense
$750K
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
$9K
Net Income
$-22M
Effective Tax Rate
—
ETR (Continuing Operations)
—
ETR Federal Statutory
21.0%
Operating Lease Cost
$4K
Income YoY Variation
-989.4%
Income QoQ Variation
-766.0%